Overview
Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults
Status:
Unknown status
Unknown status
Trial end date:
2019-04-06
2019-04-06
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
The object of clinical trial is to investigate the pharmacokinetics and safety compared to CKD-333 and co-administration CKD-330, D090 under fasting condition in healthy male adults.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Criteria
Inclusion Criteria:1. Healthy male adults aged 19 to 45 years
2. Body weight more than 50kg and within ideal body weight ±20%
3. signed informed consent form
Exclusion Criteria:
1. Have clinical significant medical history or disease that cardiovascular system,
respiratory system, kidney, endocrine system, hematological system, digestive system ,
mental illness
2. Have a gastrointestinal disease history that can effect drug absorption or surgery
3. Systolic Blood pressure≥140mmHg or Systolic Blood pressure<90mmHg, Diastolic Blood
Pressure≥90mmHg or Diastolic Blood Pressure<60mmHg